# Xylocaine

NDC: 63323-483
Generic name: LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INFILTRATION, PERINEURAL
Marketing started: 20100812

FDA application: NDA006488

## Active ingredients

- EPINEPHRINE BITARTRATE: .01 mg/mL
- LIDOCAINE HYDROCHLORIDE ANHYDROUS: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-483"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-483
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba082c2f-64f4-419d-9c88-74f203316e17